Role of peiroxisome proliferators-activated receptors in the pathogenesis and treatment of nonaloholic fatty liver disease

被引：129

作者：

Kallwitz, Eric R. ^{[1
]}

McLachlan, Alan ^{[2
]}

Cotler, Scott J. ^{[1
]}

机构：

[1] Univ Illinois, Dept Med 1, Chicago, IL USA

[2] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60680 USA

来源：

WORLD JOURNAL OF GASTROENTEROLOGY | 2008年 / 14卷 / 01期

关键词：

non-alcoholic fatty liver disease; peroxisome proliferators-activated receptors; insulin resiatance; metabolic syndrome; pharmacologic ligands;

D O I：

10.3748/wjg.14.22

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Nonalcoholic fatty liver disease (NAFLD) is highly prevalent and can result in nonalcoholic steatohepatitis (NASH) and progressive liver disease including cirrhosis and hepatocellular carcinoma. A growing body of literature implicates the peroxisome proliferators-activated receptors (PPARs) in the pathogenesis and treatment of NAFLD. These nuclear hormone receptors impact on hepatic triglyceride accumulation and insulin resistance. The aim of this review is to describe the data linking PPAR alpha and PPAR gamma to NAFLD/NASH and to discuss the use of PPAR ligands for the treatment of NASH.

引用

收藏

页码：22 / 28

页数：7

相关论文

共 108 条

[1] The natural history of nonalcoholic fatty liver disease: A population-based cohort study [J].

Adams, LA ;

Lymp, JF ;

St Sauver, J ;

Sanderson, SO ;

Lindor, KD ;

Feldstein, A ;

Angulo, P .

GASTROENTEROLOGY, 2005, 129 (01) :113-121

[2] Omega-3 fatty acids improve hepatic steatosis in a murine model:: Potential implications for the marginal steatotic liver donor [J].

Alwayn, IPJ ;

Andersson, C ;

Zauscher, B ;

Gura, K ;

Nosé, V ;

Puder, M .

TRANSPLANTATION, 2005, 79 (05) :606-608

[3] Nonalcoholic fatty liver disease [J].

Brunt, Elizabeth M. ;

Wong, Vincent W. -S. ;

Nobili, Valerio ;

Day, Christopher P. ;

Sookoian, Silvia ;

Maher, Jacquelyn J. ;

Bugianesi, Elisabetta ;

Sirlin, Claude B. ;

Neuschwander-Tetri, BrentA. ;

Rinella, Mary E. .

NATURE REVIEWS DISEASE PRIMERS, 2015, 1

[4] Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor α (PPARα) [J].

Aoyama, T ;

Peters, JM ;

Iritani, N ;

Nakajima, T ;

Furihata, K ;

Hashimoto, T ;

Gonzalez, FJ .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (10) :5678-5684

[5] Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study [J].

Athyros, Vasilios G. ;

Mikhailidis, Dimitri P. ;

Didangelos, Triandafillos P. ;

Giouleme, Olga I. ;

Liberopoulos, Evangelos N. ;

Karagiannis, Asterios ;

Kakafika, Anna I. ;

Tziomalos, Konstantinos ;

Burroughs, Andrew K. ;

Elisaf, Moses S. .

CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (05) :873-883

[6] Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia [J].

Attie, AD ;

Krauss, RM ;

Gray-Keller, MP ;

Brownlie, A ;

Miyazaki, M ;

Kastelein, JJ ;

Lusis, AJ ;

Stalenhoef, AFH ;

Stoehr, JP ;

Hayden, MR ;

Ntambi, JM .

JOURNAL OF LIPID RESEARCH, 2002, 43 (11) :1899-1907

[7] Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans - No alteration in adipose tissue of obese and NIDDM patients [J].

Auboeuf, D ;

Rieusset, J ;

Fajas, L ;

Vallier, P ;

Frering, V ;

Riou, JP ;

Staels, P ;

Auwerx, J ;

Laville, M ;

Vidal, H .

DIABETES, 1997, 46 (08) :1319-1327

[8]

Auwerx J, 1999, CELL, V97, P161

[9] Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes [J].

Bajaj, M ;

Suraamornkul, S ;

Pratipanawatr, T ;

Hardies, LJ ;

Pratipanawatr, W ;

Glass, L ;

Cersosimo, E ;

Miyazaki, Y ;

DeFronzo, RA .

DIABETES, 2003, 52 (06) :1364-1370

[10] PPAR-RXR HETERODIMER ACTIVATES A PEROXISOME PROLIFERATOR RESPONSE ELEMENT UPSTREAM OF THE BIFUNCTIONAL ENZYME GENE [J].

BARDOT, O ;

ALDRIDGE, TC ;

LATRUFFE, N ;

GREEN, S .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 192 (01) :37-45

← 1 2 3 4 5 6 7 8 9 10 →